Physician profile
Jaclyn Basso
NPI 1912396219
$1,869.06
in general payments reported to CMS, 2019-2025
21 companies · $31.49 in 2025
The $31.49 reported for 2025 was less than what a typical Pediatrics (Nurse Practitioner) provider received nationally (typical 2025 total: $93.49).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $277 · 2022: $542 · 2023: $675 · 2024: $343 · 2025: $31.49.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,050.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,049.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $430.34 | 2021-2024 | |
| Csl Behring | $212.75 | 2021-2024 | Hemgenix |
| Jazz Pharmaceuticals INC. | $160.32 | 2021-2022 | |
| Servier Pharmaceuticals LLC | $151.46 | 2022-2024 | |
| Amgen INC. | $136.20 | 2021-2023 | Blincyto |
| Grifols USA, LLC | $126.09 | 2022-2024 | Thrombate III, Gamunex-C, Alphanate |
| Sobi, INC | $116.43 | 2021-2024 | |
| Kite Pharma, INC. | $80.35 | 2024 | Yescarta |
| Takeda Pharmaceuticals U.S.A., INC. | $78.28 | 2021-2023 | Advate |
| Pfizer INC. | $59.60 | 2023 | |
| Octapharma USA, INC. | $50.65 | 2021-2022 | |
| Sanofi-Aventis U.S. LLC | $43.00 | 2021-2022 | |
| Bio Products Laboratory USA, INC. | $39.34 | 2022-2023 | Gammaplex, Coagadex |
| Rare Disease Therapeutics, INC. | $37.06 | 2021-2023 | Purixan |
| Alexion Pharmaceuticals, INC. | $32.76 | 2024 | Ultomiris |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Agios Pharmaceuticals, INC. | $31.49 | 2025 | Pyrukynd |
| Bayer Healthcare Pharmaceuticals INC. | $20.99 | 2023 | |
| Genzyme Corporation | $17.97 | 2024 | |
| Global Blood Therapeutics, INC. | $16.07 | 2022 | |
| Adaptive Biotechnologies Corporation | $15.31 | 2022 | |
| Abbvie INC. | $12.60 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jaclyn Basso listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.